#Integumen #SKIN

A company with significant short-term, mid-term, and long-term catalysts along with the potential to revolutionise the industries in which it is involved. Partnerships with #AVCT and #MWG, relationships with #PTY. A fantastic CEO in @gjbrandon

(1/15)

Partners

1. Modern Water ( #MWG) - provide water technology (virus/bacteria/contaminant detection, toxicity monitoring, desalination and water recyling). 30 years developing the tech. Gold standard. Wins Awards. In 10s of countries around the world.

(2/15)

2. Avacta #AVCT - provide affirmers to detect #COVID19

Combine the 2 = Project 1.

(3/15)

Project 1. Development of the Microtox ‘Novel-Sensor’ (NS) - #SKIN, in partnership with #MWG and #AVCT are developing the NS to detect #COVID19 LIVE (this is key) in water effluent streams (applications are endless, anything from Cruise Ships to Sewage plants).

(4/15)

#MWG could already detect if there were viruses present in water, but not ‘yet’ identify them. In theory, you can use AI and Machine Learning to identify them over time (using #SKIN subsidiary Rinocloud), or use affirmers. Step up #AVCT.

(5/15)

Beyond Covid, the Microtox NS is being developed to detect other viruses such as E-Coli and Norovirus (they have already proven that they can detect these). In theroy, we could be looking at an ‘all-in-one’ LIVE virus detection tool. Invaluable.

(6/15)

Project 2. EcowaterOS ‘is an always-connected platform, delivering real and near-time data on water state from sensors to stakeholders while also unlocking millions of completely new data points to unearth new and better ways to manage water issues.’

(7/15)

Water is soon to be the worlds most scarce resource. This project uses #MWG water monitoring equipment, retrofitted with #SKINs AI technology to monitor LIVE the state of water courses. Game-changing. The world will wake up to how important water is soon enough.

(8/15)

Project 3. #Labskin. Lab-grown skin - prevents the need of animal testing, in-person human testing and makes testing cosmetics on skin remotely possible. Huge money saver for companies, and no animals involved. Ethical. Win win. Huge market, totally unique.

(9/15)

#SKIN have just launched the worlds first ‘remote clinical trial, and it is exactly that. Volunteer skin transplanted remotely onto lab grown skin, creates an exact replica of the human. No need to leave home. No in-person contact. No safety concerns. Again, game-changing.(10/15)

Combine this with AI (Rinocloud), you have a whole clinical trial platform, full of data stored under GDPR guidelines. They are currently using Labskin (from cloned humans) coated with #COVID19 to see which/ if dental products can help prevent the spread. Results this Q.(11/15)

Financing - #SKIN have just secured a £3m debt facility which requires no repayments until 2021 to accelerate growth of all of the above. Working capital for 2020/2021 to fund the expansion/GLOBAL roll out. GB (as promised) avoided an equity placing to fund growth. (12/15)

Revenue growth - revenues have grown 400% year on year with that same multiple expected to be printed for this years revenue figures. There is upside to this number depending on when roll-out of the above takes place. (13/15)

All in all, there is so much going on here and even a lot that has not been mentioned. Investors should read all the recent RNS and follow @GB on twitter for useful updates. My biggest conviction hold and one I am very excited about. #SKIN #AVCT #MWG (14/15)